Oluyemi Okupe Sells Shares of Hims & Hers Health, Inc. $HIMS

Key Points

  • Oluyemi Okupe sold 6,376 shares of Hims & Hers Health, Inc. ($HIMS).
  • $HIMS last traded around $33.17.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Oluyemi Okupe, Chief Financial Officer at Hims & Hers Health, Inc. ($HIMS), sold 6,376 shares at an average price of $0. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

Hims & Hers Health, Inc. Stock Up 15.0%

Shares of Hims & Hers Health, Inc. ($HIMS) traded around $33.17 on Wednesday, up 15.0% for the day.

Last price$33.17
Market cap$6.90B
Forward P/E29.51
PEG ratio2.15
Beta2.42
52-week low$13.74
52-week high$65.30
50-day MA$31.99
200-day MA$28.55
Current ratio0.93
Quick ratio0.82
Debt-to-equity4.77

Hims & Hers Health, Inc. Earnings

EPS (ttm)-$0.66
Revenue (ttm)$2.58B
Revenue growth38.20%
Net margin-5.51%
Return on equity-32.03%
Next earningsNov 9, 2026

Analysts Set New Price Targets

ConsensusHold
Average target$31.23
High target$42
Low target$23
Analysts covering13

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

ExchangeNYSE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSan Francisco, CA
CEOMr. Andrew Dudum
Employees2,442

Get Hims & Hers Health, Inc. alerts

New 13F filings, insider trades, and analyst moves on $HIMS, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.